There is a lack of data on circulating levels of cell-adhesion molecules in relation to subclinical atherosclerosis measured in both the carotid and femoral arteries in humans. The aim of the present study was to investigate the relationship between clinically silent atherosclerosis and cell-adhesion molecules, and to explore the relationship between these molecules, C-reactive protein and the inflammatory cytokines interleukin-6, tumour necrosis factor-α (TNF-α), soluble TNF-α receptor p55 and soluble TNF-α receptor p75. The study group (n l 391) consisted of clinically healthy 58-year-old men recruited from the general population. The results showed a positive trend between levels of soluble intercellular cell-adhesion molecule 1 (sICAM-1) and plaque occurrence in the carotid and femoral arteries (P l 0.008), and also a univariate correlation between sICAM-1 levels and the composite variable of carotid and femoral intimamedia thickness (P 0.001). When adjusted for other risk factors, the relationship between sICAM-1 and intima-media thickness no longer reached statistical significance. The level of sICAM-1 was associated with those of the pro-inflammatory cytokine TNF-α, its two soluble receptors, and also interleukin-6 and C-reactive protein. Levels of soluble E-selectin and vascular cell-adhesion molecule 1 (VCAM-1) showed weak or no association with subclinical atherosclerosis and inflammatory variables. Thus, in clinically healthy middle-aged men, levels of sICAM-1, but not of soluble VCAM-1 or E-selectin, were associated with both subclinical atherosclerosis and inflammatory variables.
INTRODUCTION
C-reactive protein (CRP), an acute-phase protein, is a sensitive marker of inflammation and infection [1] . Inflammation has also been postulated to play an molecules, such as intercellular cell-adhesion molecule 1 (ICAM-1), vascular cell-adhesion molecule 1 (VCAM-1) and selectin, which are expressed on the surface of vascular endothelial cells, and also by other cells [5] [6] [7] [8] [9] [10] [11] [12] . It is currently believed that the selectins mediate the initial rolling of leucocytes along the endothelium, and that VCAM-1 and ICAM-1 induce attachment to and migration through the endothelium. VCAM-1 is involved primarily in the adhesion of mononuclear leucocytes to the endothelium, and is rapidly induced by the proinflammatory cytokines interleukin-1 (IL-1) and tumour necrosis factor-α (TNF-α) [13] . ICAM-1 is expressed on many cell types and is involved in both monocyte and lymphocyte adhesion to the endothelium [13] . E-selectin is an endothelium-specific adhesion molecule, and seems to affect the adhesion of polymorphonuclear leucocytes, monocytes and lymphocytes (summarized in [13] ).
Cellular adhesion molecule expression has been detected in several components of human atheroma [14] . Circulating forms of cell-adhesion molecules have been detected in plasma, possibly caused by shedding from the endothelium [15] . Cross-sectional and prospective data suggest that soluble forms of these proteins are elevated among patients with diverse manifestations of atherosclerosis [16] [17] [18] [19] [20] [21] . A few previous studies have also indicated that ICAM-1 [21, 23, 24] , VCAM-1 [23] and\or E-selectin [21] are elevated in subjects with carotid atherosclerosis, as measured by ultrasound. However, none of these previous studies have included femoral intima-media thickness (IMT) or plaque occurrence in the analyses.
The development of the B-mode ultrasound technique has made it possible to study the atherosclerotic process non-invasively. IMT of the carotid artery has been used as a non-invasive indicator of the atherosclerotic process in the coronary arteries [25] . IMT of the carotid bulb and plaque occurrence and size in the carotid artery have also been shown previously to be associated with coronary atherosclerosis, as measured by coronary angiography [26] .
The main aims of the present study were to investigate the relationship between clinically silent atherosclerosis, as measured by ultrasound in the carotid and femoral arteries, and levels of cell-adhesion molecules, and also to explore the relationship between these molecules, CRP and the inflammatory cytokines IL-6, TNF-α, soluble TNF-α receptor p55 (sTNFR1) and soluble TNF-α receptor p75 (sTNFR2). These observations were made in clinically healthy 58-year-old men recruited from the general population.
METHODS

Study group
The inclusion criteria were male sex, age 58 years, and Swedish ancestry. Exclusion criteria were cardiovascular disease (myocardial infarction, angina pectoris, stroke, intermittent claudication, aortic disease) or other established disease, treatment with cardiovascular drugs (i.e. anti-diabetic, lipid-lowering, anti-hypertensive or heart failure drugs, or drugs for angina pectoris) which might disturb the measurements performed in the study, and unwillingness to participate. No subjects with clinically overt diabetes were included. However, fasting blood glucose of 6.1 mmol\l was found in 22 subjects (5.6 %). The subjects were selected randomly from men in the County Council register. The design was a cross-sectional study based on a stratified sampling of randomly selected and screened men with the aim to include men with different degrees of obesity and insulin sensitivity, as described previously in detail [27] . Study group characteristics are summarized in Table 1 .
The present study is a substudy in a project in which the main objective was to examine the relationship between insulin peptides, the metabolic syndrome and atherosclerosis as assessed by ultrasound [28] . A power calculation indicated that at least 750 men had to be screened in order to recruit 390 men into the study.
The subjects received both written and oral information before they gave their consent to participate. The study was approved by the Ethics Committee at Sahlgrenska University Hospital.
Ultrasonography
IMT
Examination was performed with an ultrasound scanner (Acuson 128) with a 7 Mhz linear transducer aperture of 38 mm. The ECG signal (lead II) was recorded simultaneously to synchronize the image capture of the top of the R wave, in order to minimize variability during the cardiac cycle. Both the left and right carotid arteries were scanned at the level of the bifurcation, and images for IMT measurements were recorded from the far wall in the common carotid artery and the carotid artery bulb, and from the right femoral artery. The software program gives the average thickness of the intima-media complex. Measurements in the common femoral artery were made in a similar way as for the carotid artery, but along a 15 mm-long section proximal to the bifurcation [29] . IMT was defined as the distance from the leading edge of the lumen-intima interface to the leading edge of the mediaadventitia interface of the far wall. At the position of the thickest part of the wall ( judged visually), a frozen longitudinal image was captured and recorded on videotape. The procedure was repeated four times to achieve four separate images for analysis. A short sequence of real-time images was also recorded on videotape to assist in the interpretation of the frozen images. The images were measured in an automated analysing system [30] , based on automatic detection of the echo structures in the ultrasound image, but with the option of manual corrections by the operator. The inter-observer variation for IMT has been shown to be satisfactory [31] . Measurements of carotid and femoral artery IMT were available for 379 and 373 men respectively.
Assessment of plaque occurrence
The carotid and femoral arteries were scanned both longitudinally and transversely to assess the occurrence of plaques [29] . A plaque was defined as a distinct area with an IMT more than 50 % greater than in neighbouring sites ( judged visually). A semi-quantitative subjective scale was used to grade the size of plaques : grade 1, one or more small plaques (less than approx. 10 mm#) ; grade 2, moderate to large plaques (the differentiation between grades 1 and 2 was made subjectively in most cases, and quantitative measurements were made in the computerized system [32] only when the correct classification was not obvious to the observer) ; grade 3, plaques giving flow disturbances [30] . In the present study, no plaque of grade 3 was found in the femoral artery and three subjects had plaques of grade 3 in the carotid artery. Therefore plaques of grades 2 and 3 were merged into one group of moderate to large plaques. This analysis included plaques in the near wall as well as the far wall of the vessel. Analyses of plaques were performed in both the right and left carotid arteries. The largest plaque in either artery was used in the present analysis. In a re-reading reproducibility study (n l 45) of plaque size there were high correlation coefficients for the right and left carotid arteries (r s l 0.96 and r s l 0.96 respectively) and also for the right femoral artery (r s l 0.86). Measurements of plaques in the carotid and femoral arteries were available for 367 and 389 men respectively.
Blood sampling
Venous blood was obtained in the morning after an overnight fast. Serum was separated within 4 h and kept frozen at k70 mC until assayed.
Cell-adhesion molecules
Circulating levels of soluble (s)VCAM-1, sE-selectin and sICAM-1 were determined using commercially available ELISAs and standards (R&D System Europe Ltd.). The between-assay variation was determined by comparing the same blood samples (n l 41) on two different plates. The coefficients of variation were 3.3 %, 5.1 % and 4.8 % for sVCAM-1, sE-selectin and sICAM-1 levels respectively.
Biochemical analysis
Blood samples for serum cholesterol, serum triacylglycerols and lipoprotein fractions were drawn after a fasting period of 10-12 h. Cholesterol and triacylglycerol levels were determined by fully enzymic techniques [33, 34] . High-density lipoprotein was determined after precipitation of apolipoprotein B-containing lipoproteins with MnCl # and dextran sulphate. Low-density lipoprotein (LDL) cholesterol was calculated as described by Friedewald et al. [35] . High-sensitivity ELISA kits were used to measure IL-6 (R&D System Europe Ltd), TNF-α (R&D System Europe Ltd) and CRP (Medix Biochemica, Kauniainen, Finland). ELISA kits were also used to measure sTNFR1 and sTNFR2 (R&D System Europe Ltd). All analyses were performed at the Wallenberg Laboratory.
Statistical analysis
All statistical analysis was performed using SPSS for Windows 10.0 (SPSS, Chicago, IL, U.S.A.). Trend analysis was performed by using Mantel's test. Skewed variables were logarithmically transformed before statistical testing. Multiple regression was used to explore whether the association between sICAM-1 and IMT was independent of other co-variates. Simple Spearman's rank correlation coefficients were used to calculate univariate associations. In the correlation analyses, P 0.01 was regarded as statistically significant ; otherwise, P 0.05 (two-sided) was regarded as statistically significant. 
RESULTS
Relationships between cell-adhesion molecules and plaque occurrence in the carotid and femoral arteries
There was a positive trend between carotid and femoral IMT and plaque occurrence in the carotid and femoral arteries (Table 2) . Furthermore, there was also a positive trend between sICAM-1 levels and plaque occurrence in the carotid and femoral arteries (Table 2) . However, no significant associations were observed between levels of sE-selectin or sVCAM-1 and plaque occurrence in the carotid and femoral arteries ( Table 2) .
Relationships between IMT and celladhesion molecules
Elevated sICAM-1 levels were significantly associated with femoral IMT (r l 0.20, P 0.001) (Table 3) , as well as with the composite measure of IMT in the common carotid, the carotid bulb and the common femoral artery (r l 0.20, P 0.001) ( Table 3) . Elevated sE-selectin levels were associated with IMT in the carotid artery bulb (r l 0.15, P l 0.004) ( Table 3) . sE-selectin levels also tended to be associated with the composite IMT measure (r l 0.10, P l 0.049). No significant associations were seen between sVCAM-1 levels and IMT in the carotid and femoral arteries (Table 3) . The composite measure of IMT in the common carotid, the carotid bulb and the common femoral artery was univariately associated with (in addition to sICAM-1) systolic blood pressure (r l 0.34), total cholesterol (r l 0.23), triacylglycerols (r l 0.33), waist\ hip ratio (r l 0.22), LDL particle size (r l k0.23), cigarette-years (r l 0.42) and CRP (r l 0.17) (P 0.01 for all associations). When adjusting for these risk factors in a multiple regression model, no independent association was observed between composite IMT and sICAM-1 levels. In a stepwise forward multiple regression model, cigarette-years (F-value l 68), systolic blood pressure (F l 57), total cholesterol (F l 47) and triacylglycerols (F l 37) explained 30 % of the variability in composite mean IMT (P 0.001). Correlations between cell-adhesion molecules, CRP, cytokines, blood pressure, cholesterol and smoking Levels of sICAM-1, sVCAM-1 and sE-selectin were positively and significantly inter-related (Table 4) . sICAM-1 was in addition also significantly positively associated with TNF-α, sTNFR1, sTNFR2, IL-6, systolic blood pressure and smoking (Table 4) . sVCAM-1 was positively associated with sTNFR1 and sTNFR2, and negatively associated with total cholesterol (Table 4) . sE-selectin was associated with TNF-α, TNFR2, IL-6 and systolic blood pressure (Table 4) .
DISCUSSION
The results of the present study showed that sICAM-1 levels were related to IMT and plaque occurrence in the carotid and femoral arteries in apparently healthy 58-year-old men. In addition, sICAM-1 was consistently associated with the pro-inflammatory cytokine TNF-α, its two soluble receptors, and IL-6 and CRP. sICAM-1 was also associated with systolic blood pressure and smoking, but not with total cholesterol levels. When adjusting for other risk factors, such as systolic blood pressure, cholesterol and smoking, the observed relationship between ICAM-1 and IMT no longer reached statistical significance. Significant associations between circulating sICAM-1 levels and the sequelae of atherosclerosis have been reported in previous studies [17] [18] [19] [20] [21] 36, 37] . In the Physicians Health Study (PHS), approx. 15 000 subjects were followed over a 9-year period for the occurrence of a first ever myocardial infarction [20] . In this cohort a significant association was found between increasing baseline concentrations of sICAM-1 and the risk of future myocardial infarction. In the Atherosclerosis Risk In Communities (ARIC) study, higher plasma concentrations of sICAM-1 at study entry were associated with an increased risk of future coronary heart disease [21] .
The importance of sICAM-1 in the development of atherosclerosis is also supported by a few cross-sectional studies showing a relationship between sICAM-1 levels and carotid atherosclerosis, as measured by ultrasound [21, 23, 24] , and also by a study showing a significant relationship between peripheral artery disease and sICAM-1 levels [17] . However, the picture is not entirely consistent. In two recent studies in patients with coronary atherosclerosis, no significant association was seen between sICAM-1 levels and coronary artery disease [22, 38] .
In contrast with the present study, none of these previous studies investigated the relationship between circulating levels of cell-adhesion molecules and subclinical atherosclerosis in both the carotid and femoral arteries. As it is reasonable to assume that circulating celladhesion molecules are released from different parts of the vascular tree, we chose in the present study to measure subclinical atherosclerosis not only in the common carotid artery, but also in the carotid bulb and the femoral artery. Furthermore, in order to estimate the overall atherosclerosis burden, we defined subjects without plaque occurrence (both carotid and femoral arteries), subjects with plaque occurrence in either artery, and subjects with plaque occurrence in both arteries. The results showed an association between plaque occurrence and sICAM-1 levels, i.e subjects with plaque occurrence in both arteries had higher sICAM-1 levels compared with the other groups. These results were obtained independently of plaque size. However, subjects with plaque occurrence in both arteries also had a high frequency of moderate\large plaques in the carotid (59 %) as well as in the femoral (78 %) artery. Hence the results from the present study showing a relationship between subclinical atherosclerosis in the carotid and femoral arteries (both IMT and plaque occurrence) and sICAM-1 levels in a group of clinically healthy middleaged men corraborate earlier findings suggesting that sICAM-1 might play an important role in the development of atherosclerosis. However, it should be noted that the relationship between IMT and sICAM-1 levels was not independent of other risk factors in the present study.
In the present study, sVCAM-1 levels were not significantly associated with subclinical atherosclerosis in the carotid and femoral arteries, whereas sE-selectin levels were significantly associated with carotid bulb IMT, but not with plaque occurrence or the composite mean of common carotid, carotid bulb and femoral IMT. Contrary to these findings, VCAM-1 has recently been suggested to play a major role in atherosclerosis development in mice [39] . However, data from humans are inconsistent. Positive [16, 17, 22, 23, 37] as well as negative [18, 19, 21, 24, 36] results have been published regarding a relationship between sVCAM-1 and atherosclerotic disease and its complications in humans. The same holds true for sE-selectin, where both positive [18, 21, 22] and negative [16, 24, 37] studies have been published. Whether these discrepancies are due to different expression of celladhesion molecules in different phases of the atherosclerotic process, that may range from the slow growth of atherosclerotic plaques to complicated lesions, has still to be elucidated.
CRP is a sensitive marker of inflammation and infection. The production of CRP is regulated by cytokines, including IL-1, IL-6 and TNF-α [40] . TNF-α induces cellular responses after binding to specific cell surface receptors, i.e. TNFR1 and TNFR2 [41] . It is not known whether CRP exerts a direct effect on the atherosclerotic process or if serum CRP elevation is a phenomenon secondary to the impact of other factors. However, it has been suggested that CRP might have a direct effect on the vascular endothelium. Recently, Pasceri et al. [42] showed that CRP induced adhesion molecule expression in human coronary endothelial cells in the presence of serum. In this context, the observed relationships between sICAM-1, TNF-α, IL-6, TNFR1 and TNFR2 are interesting. It is known that several inflammatory cytokines, including IL-1 and TNF-α, may stimulate the endothelium to up-regulate genes encoding adhesion molecules [43] . Also, IL-6 has been shown to induce ICAM-1 expression on human umbilical endothelial cells [44] . In the present study sICAM-1 was consistently associated with the pro-inflammatory cytokine TNF-α, and its two soluble receptors, IL-6 and CRP. Therefore CRP, as well as regulatory cytokines and receptors, seem to be important regulators of sICAM-1 in humans.
To summarize, the present study has shown associations between sICAM-1 concentration, plaque occurrence and IMT in the carotid and femoral arteries ; however, this relationship did not retain statistical significance after adjustment for traditional cardiovascular risk factors. sICAM-1 levels were also consistently associated with those of the pro-inflammatory cytokine TNF-α, its two soluble receptors, IL-6 and CRP. In contrast, levels of sE-selectin and sVCAM-1 showed no or inconsistent associations with both subclinical atherosclerosis and inflammatory variables.
